SCHEMBL29959795

SCHEMBL29959795

CCOc1ccc(C)cc1S(=O)(=O)Cl

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
POLB P06746 3/20 0.58
MAPK1 P28482 2/20 0.56
HSD17B10 Q99714 1/20 0.56
L3MBTL1 Q9Y468 3/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
NPSR1 Q6W5P4 1/20 0.53
TRPV4 Q9HBA0 1/20 0.51
NPC1 O15118 2/20 0.51
ALPL P05186 1/20 0.51
MAPT P10636 3/20 0.45
RAB9A P51151 2/20 0.45
ALDH1A1 P00352 1/20 0.45
ATM Q13315 1/20 0.45
HPGD P15428 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7870540 1.00 TSHR (0.58) TSHRMEN1KMT2APOLBMAPK1
SCHEMBL25045969 0.86 TRPV4 (0.63) TSHRMEN1KMT2APOLBMAPK1
SCHEMBL34468880 0.83 TSHR (0.58) TSHRMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL2703971 0.83 TSHR (0.62) TSHRKMT2AL3MBTL1SMN1; SMN2NPSR1
SCHEMBL29469925 0.83 MEN1 (0.58) TSHRMEN1KMT2APOLBMAPK1
SCHEMBL2701151 0.81 GAA (0.58) TSHRMEN1KMT2APOLBSMN1; SMN2
SCHEMBL21609096 0.81 TRPV4 (0.50) TSHRMEN1KMT2APOLBMAPK1
SCHEMBL24314192 0.81 TRPV4 (0.50) TSHRMEN1KMT2APOLBSMN1; SMN2
SCHEMBL12325147 0.81 KDM4E (0.51) TSHRMEN1KMT2APOLBMAPK1
SCHEMBL739940 0.80 KMT2A (0.60) TSHRMEN1KMT2APOLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230000827-A1 INHIBITORS OF HSP70 PROTEIN INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2023-01-05 US disclosed
EP-4061363-A1 INHIBITORS OF HSP70 PROTEIN Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2022-09-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230000827-A1 INHIBITORS OF HSP70 PROTEIN HSPBP1, HSPH1, HSPA2 TSHR 4175/4885MEN1 4654/4885KMT2A 4117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.